NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 248 filers reported holding NEOGENOMICS INC in Q3 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $414,254 | -41.7% | 25,851 | -66.4% | 0.00% | -40.0% |
Q4 2022 | $710,329 | -16.1% | 76,879 | -21.8% | 0.01% | -16.7% |
Q3 2022 | $847,000 | -90.7% | 98,316 | -63.3% | 0.01% | -89.7% |
Q4 2021 | $9,151,000 | -27.1% | 268,194 | +3.1% | 0.06% | -31.8% |
Q3 2021 | $12,548,000 | +48.3% | 260,120 | +38.9% | 0.08% | +46.6% |
Q2 2021 | $8,462,000 | -44.8% | 187,332 | -36.8% | 0.06% | -54.7% |
Q1 2021 | $15,335,000 | -4.0% | 296,519 | -0.0% | 0.13% | +1.6% |
Q4 2020 | $15,966,000 | +1137.7% | 296,528 | +747.6% | 0.13% | +950.0% |
Q3 2020 | $1,290,000 | -92.6% | 34,983 | -93.8% | 0.01% | -93.5% |
Q2 2020 | $17,415,000 | +30.5% | 562,098 | +20.5% | 0.18% | +24.3% |
Q1 2020 | $13,343,000 | -2.2% | 466,665 | +0.0% | 0.15% | +1.4% |
Q4 2019 | $13,648,000 | +174.3% | 466,584 | +79.3% | 0.15% | +121.2% |
Q3 2019 | $4,975,000 | +29.3% | 260,201 | +47.7% | 0.07% | +37.5% |
Q2 2019 | $3,849,000 | +41.2% | 176,201 | +32.3% | 0.05% | +37.1% |
Q1 2019 | $2,725,000 | – | 133,201 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 1,614,263 | $19,613,000 | 10.60% |
Samjo Capital LLC | 185,000 | $2,248,000 | 1.92% |
PERKINS CAPITAL MANAGEMENT INC | 152,550 | $1,853,000 | 1.52% |
Cowen Prime Advisors LLC | 183,500 | $2,230,000 | 0.94% |
First Light Asset Management, LLC | 805,958 | $9,792,000 | 0.86% |
Soleus Capital Management, L.P. | 460,000 | $5,589,000 | 0.72% |
Greenhouse Funds LLLP | 574,956 | $6,986,000 | 0.70% |
Bullseye Asset Management LLC | 108,054 | $1,313,000 | 0.60% |
Ranger Investment Management | 776,428 | $9,434,000 | 0.60% |
EMERALD MUTUAL FUND ADVISERS TRUST | 960,832 | $11,674,000 | 0.52% |